Key facts
- Violet (Healthcare Technology Systems)’s last known valuation is $15.3M (Jun 2022).
- It has raised $7.7M; the latest was Later Stage VC ($2.4M) in Jan 2025.
- Notable investors include Right Side Capital Management, Gaingels, Village Capital, Forum Ventures, SemperVirens Venture Capital — 24 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Violet (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Violet (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Violet (Healthcare Technology Systems)
Developer of a health equity platform designed to make it easier for healthcare organizations to deliver inclusive care. The company's platform benchmarks cultural competencies within healthcare organizations, educating clinical teams to become more culturally competent, enabling healthcare firms to reach new patients and retain more of these patients by care routine effectively.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 20
- Website
- joinviolet.com/
- Ownership
- Privately Held (backing)
Violet (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Violet (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Violet (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.